Morgan Stanley is set to report earnings — here’s what to expect

Morgan Stanley is expected to report third-quarter EPS of $2.91 and revenue of $19.95 billion before Wednesday’s opening bell; estimates include $2.27 billion in investment banking revenue, $4.89 billion in equities trading, and $2.27 billion in fixed-income trading. Analysts expect robust investment banking and equities trading, and will focus on CEO Ted Pick’s outlook for mergers and IPOs amid rising interest rates. The article reports expectations, not actual results.

Analysis

The key read-through is not whether MS clears a quarterly bar, but whether management sees enough durable deal momentum to offset the risk that strong trading is a market-volatility windfall rather than a repeatable earnings run-rate. Peer results may raise the bar for the print, while leaving the more valuable signal—forward M&A and IPO conversion—unresolved. Rising rates cut both ways: volatility can support client trading, but higher financing costs and valuation uncertainty can defer transactions, weakening the next-quarter pipeline.

Near term, expect a headline beat to have limited staying power unless guidance or commentary validates deal activity beyond the reported quarter. Over 1–3 months, monitor announced mandates converting to completed deals, IPO issuance, and any change in management’s pipeline language. Over 6–18 months, sustained issuance and M&A would support investment-banking earnings; a rates-driven freeze would expose dependence on episodic trading strength. The contrarian risk is treating peers’ strong quarters as proof of a sector-wide, durable recovery before transaction volumes confirm it.

Key Decisions for Investors

• Avoid a blind pre-earnings directional position in MS: the event is binary and the forward pipeline matters more than a small EPS surprise. Reassess after the call for evidence of improving M&A and IPO conversion.
• Conditional trade: if MS raises confidence in deal activity while trading remains firm, consider a measured long MS versus GS, sized as a relative-value expression rather than a broad bank-sector bet. Do not initiate on a beat alone; the thesis weakens if MS’s forward pipeline commentary lags peers.
• If results are trading-led but management describes deal activity as delayed or uncertain, fade any initial post-print rally or stay underweight MS; watch subsequent revisions to investment-banking expectations as the confirmation signal.
• Falsifiers and alerts: a clear deterioration in deal pipeline commentary, falling IPO issuance or M&A completion activity, or a sustained rise in rates that stalls financing markets would challenge the recovery thesis. Verify the call’s pipeline disclosures and guidance; the article provides no basis to quantify valuation upside or downside.